头孢哌酮舒巴坦钠联合美罗培南治疗细菌感染性重症肺炎患儿的临床疗效
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

安徽省卫健委基金资助项目(2016ek005);


Curative effect of cefoperazone sulbactam sodium combined with mero-penem in children with severe pneumonia induced by bacterial infection
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探讨头孢哌酮舒巴坦钠(CPZ-SBT)联合美罗培南治疗细菌感染性重症肺炎患儿的临床疗效。方法:选取108例细菌感染性重症肺炎患儿为研究对象,根据治疗方式不同分为联合组和对照组,每组各54例。对照组患儿给予CPZ-SBT治疗;联合组患儿给予CPZ-SBT联合美罗培南治疗,疗程均为7 d。比较两组患儿临床疗效、症状消退时间、细菌清除率、病情危重程度[小儿危重症(PICS)评分和急性生理与慢性健康量表Ⅱ(APACHEⅡ)评分]、T细胞亚群(CD4+T细胞、CD8+T细胞及CD4+/CD8+T)、炎症因子[C反应蛋白(CRP)、降钙素原(PCT)、可溶性细胞间粘附分子1(sICAM-1)]水平及不良反应发生情况。结果:联合组患儿治疗有效率高于对照组(P<0.05);发热消退时间、咳嗽缓解时间、湿啰音消失时间短于对照组(P<0.05);细菌清除率高于对照组(P<0.05);PICS评分、APACHEⅡ评分低于对照组(P<0.05);CD4+T细胞、CD4+/CD8+比值高于对照组(P<0.05),CD8+T细胞水平低于对照组(P<0.05);CRP、PCT、sICAM-1水平低于对照组(P<0.05)。两组患者不良反应总发生率比较,差异无统计学意义(P>0.05)。结论:CPZ-SBT联合美罗培南对细菌感染性重症肺炎患儿疗效好,能有效清除感染细菌,提高免疫功能,减轻炎症反应。

    Abstract:

    Objective;To explore the clinical curative effect of cefoperazone sulbactam sodium(CPZ-SBT)combined with mero-penem in children with severe pneumonia induced by bacterial infection.Methods:108 children with severe pneumonia induced by bac-terial infection were selected as the research subjects.According to different treatment methods,children were divided into control group(CPZ-SBT)and combination group(CPZ-SBT combined with meropenem),54 cases in each group.The course of treatment was 7 days.The curative effect,fading time of symptoms,bacterial clearance rates,scores of critical illness(PICS score and APACHE Ⅱscore),T cell subsets(CD4+T cells,CD8+T cells,and CD4+/CD8+T),inflammatory factors[C-reactive protein(CRP),procalcito-nin(PCT),soluble intercellular adhesion molecule-1(sICAM-1)]and adverse drug reactions were compared between the two groups.Results:Compared with control group,response rate of treatment was higher in combination group(P<0.05),antipyretic time,remis-sion time of cough and disappearance time of moist rale were shorter(P<0.05),bacterial clearance rate was higher(P<0.05).cough score was higher(P<0.05),and PICS score and APACHE Ⅱ score were lower(P<0.05).The levels of CD4+T cells and CD4+/CD8+ratio in combination group were higher than those in control group,while the levels of CD8+T cells was lower in combina-tion group(P<0.05).The levels of CRP,PCT and sICAM-1 in combination group were lower than those in control group(P<0.05).The difference in the total incidence of adverse reactions between combination group and control group was not statistically significant(P>0.05).Conclusion:Curative effect of CPZ-SBT combined with meropenem is significant in children with severe pneumonia induced by bacterial infection,which can effectively clear infectious bacteria,enhance immune function and relieve inflammatory response.

    参考文献
    相似文献
    引证文献
引用本文

童仁香;常甄瑱;陈倩;房红娟;夏蔚;.头孢哌酮舒巴坦钠联合美罗培南治疗细菌感染性重症肺炎患儿的临床疗效[J].川北医学院学报,2025,40(2):210-214.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-24
  • 出版日期:
文章二维码